Model Medicines is a company that develops AI and machine learning-based drug discovery solutions for the pharmaceutical sector. It offers GALILEO, a platform to discover and develop drugs by modeling biology and chemistry; and CHEMprint, a drug discovery platform that creates a pipeline of medicines for untreated diseases. The company also provides a pipeline of patent-pending therapeutics for oncology, infectious diseases, gastric disorders, neurological disorders, and weight disorders.